EyePoint Pharmaceuticals: A Boon for Eye Disease Patients
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) develops and commercializes therapeutics to improve the lives of patients with severe eye disorders. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) Market Cap: $1.02B; Current Share Price: 19.93 USD Data by YCharts The Company and its Products EyePoint’s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug...
